Wed, Jan 28, 2015, 5:09 AM EST - U.S. Markets open in 4 hrs 21 mins


% | $
Quotes you view appear here for quick access.

diaDexus, Inc. Message Board

jwilbanks 7 posts  |  Last Activity: Jan 21, 2015 4:38 PM Member since: Feb 17, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • jwilbanks Jan 21, 2015 4:38 PM Flag

    So how does this help audc? Lync is a separate license.

    Sentiment: Buy

  • CEO Stanley Erck insists that "the vaccinated baboons died of embarrassment, not Ebola".

    Sentiment: Strong Sell

  • by jwilbanks Dec 29, 2014 9:42 PM Flag

    by last day of 2014...$7.10, Then... by end of January, I'm betting on $9 to $11... 12-31-14

    I fully expect that in another two months, the shares will be another $2 higher.... and maybe $4 higher.... what a great investment this is. 12-18-14

    look for a massive short covering and a price of $10 to $15.... It's coming... 12-1-14

    the shares could be $100 in a few years... 11-26-14

    end of next week we could see $7..11-20-14

    It seems that $10+ by Q2, '15 is quite doable. 11-14-14

    you'll be able to sell the NVAX shares at around $10 to $15 in Q1. 11-10-14

    I see the $20s ahead as usual. 11-5-14

    NVAX will see $50 to $100. 10-28-14

    By December when the trial starts... the share price will be more realistic (reflecting the true value) at over $12 to closer to $20.... 10-27-14

    Our suggestions of a $50 to $100 share price are simply not exaggerations in a 2-4 year time frame. And $30 in 9 months to 18 months is all but certain, in my view. As you say... we are already over $10 and we just don't know it yet. 10-26-14

    $30 is so much more a today target. 10-23-14

    $5 is but a tiny step on the stairs to $10 and $20. 10-21-14

    I'll repeat "$10 to $20 within 6 months. 10-20-14

    $6... then $8... then $12.... then $16.... and on to buyout price of $20 to $30. 10-16-14

    $12.50 is too little. $20 to $30 is attainable in a year to 18 months. 10-9-14

    NVAX shares are at $30 or $50 in two years. 10-6-14

    it makes me sick to see nvax miss out on the surge in ebola related stock moves. 10-3-14

    Sentiment: Strong Sell

  • Reply to

    End of year prediction

    by stockalias Dec 24, 2014 11:42 AM jwilbanks Dec 29, 2014 6:15 PM Flag

    You want your baby to turn into a beautiful bride. So you have to dress it up a little bit, well a lot. I get it.

    Sentiment: Strong Sell

  • Reply to

    A big question

    by climbhigh111 Dec 29, 2014 5:50 PM jwilbanks Dec 29, 2014 6:02 PM Flag

    If this were a 7 year old biotech instead of a 27 year old, someone might believe in them. They are well past the point of needing to prove themselves. Despite the board's giddiness, Every p2 is meaningless at this point. The biotech graveyard is filled with company's brimming with promising p2's. All that matters is p3 results. And how many/what are the dilutions that get it there? Too many uncertainties for any Big Pharm to get excited. They've all been there and done it. You haven't. But that's right, It was the prior management not the current management that was scamming you. Oh the Humanity!

    Sentiment: Strong Sell

  • Reply to

    End of year prediction

    by stockalias Dec 24, 2014 11:42 AM jwilbanks Dec 26, 2014 12:36 PM Flag

    1) Trials all take longer than expected. Average to below average results but nvax spins them to be spectacular. The baboons all vote nvax as the greatest play place on the planet. Nvax announces an award for their humane treatment of the baboons - then floats a 50 million share secondary at $5 per share.
    2) Stock ends 2015 under $4

    Sentiment: Strong Sell

  • Does the market just see Enterprise focused providers like audc as less attractive? This last quarter was hurt by a "one off" transaction - whatever that was. Dell, EMC, Hp, Cisco, etc.. (unlike the good ole days) have all been getting their #$%$ handed to them by enterprise that relentlessly negotiates the contract. My wag is that this "one off" was just part of a contract that audc had to accept to get the sale. So was that really a one off transaction or is this the shape of things to come? Time will tell as the company was very opaque about it. All comments welcomed

    Sentiment: Buy

0.550.00(-0.88%)Jan 27 3:52 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Apple Inc.
NASDAQTue, Jan 27, 2015 4:00 PM EST
Microsoft Corporation
NASDAQTue, Jan 27, 2015 4:00 PM EST
Horizon Pharma plc
NASDAQTue, Jan 27, 2015 4:00 PM EST